Brink's Co Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
13.8%projected annual EPS growth
Analyst Coverage
2analysts covering
FY Revenue (est.)
$5.6Bnext fiscal year
FY EPS (est.)
$9.20next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release and Conference Call | 4 Nov 2026 |
| Expected Closing of NCR Atleos Acquisition | 31 Mar 2027 |
Monitoring Framework
Key Performance Indicators
AMS/DRS Organic Revenue Growth Quarterly1,500.0%Target: Mid-to-high teens
Total Organic Revenue Growth Quarterly450.0%Target: Mid-single digit
Adjusted EBITDA Margin Expansion Quarterly1,730.0%Target: 30 to 50 basis points expansion annually
Free Cash Flow Conversion Rate Quarterly5,000.0%Target: 40% to 45%
Watch Items
- NCR Atleos Acquisition Regulatory and Shareholder ApprovalsTrigger: Delays beyond Q1 2027 target close dateAction: Re-evaluate integration timeline, synergy realization pacing, and bridge financing costs.
- Consolidated Net Leverage RatioTrigger: Leverage remaining above 2.7x EBITDA without path to 2.3x by year-end 2026Action: Enforce strict pause on share repurchases and prioritize free cash flow allocation to debt paydown.
- Foreign Currency Translation VolatilityTrigger: Significant negative impact on GAAP reported revenue and EPSAction: Monitor constant-currency performance metrics and adjust quarterly hedging strategies.
Research as of 19 Jun 2026